RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.
about
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
RAS pathway mutations as a pre ...... acute lymphoblastic leukemia.
@en
RAS pathway mutations as a pre ...... acute lymphoblastic leukemia.
@nl
type
label
RAS pathway mutations as a pre ...... acute lymphoblastic leukemia.
@en
RAS pathway mutations as a pre ...... acute lymphoblastic leukemia.
@nl
prefLabel
RAS pathway mutations as a pre ...... acute lymphoblastic leukemia.
@en
RAS pathway mutations as a pre ...... acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1433
P1476
RAS pathway mutations as a pre ...... acute lymphoblastic leukemia.
@en
P2093
A Q Hoogkamer
C van de Ven
E M P Steeghs
G Escherich
H A de Groot-Kruseman
I S Jerchel
P2860
P2888
P304
P356
10.1038/LEU.2017.303
P577
2017-10-03T00:00:00Z